{
  "case_id": "MN15-19648",
  "year": 2015,
  "patient_info": {
    "age_range": "51 to 64",
    "gender": "Female"
  },
  "diagnosis": "CNS/ Neuromusc Dis",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [
    "memory disturbance",
    "requires assistance",
    "requires assistance",
    "requires assistance"
  ],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Other",
  "treatments_requested": [
    {
      "name": "Memantine",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "treatments_tried_but_failed": [],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity"
  ],
  "other_issues": null,
  "guidelines_support": true,
  "guidelines_not_support": null,
  "guidelines_details": "According to the Alzheimer\u2019s Association, the patient's symptoms support a diagnosis of moderate Alzheimer\u2019s, which supports the use of Namenda.",
  "soc_support": true,
  "soc_not_support": null,
  "soc_details": "The use of Namenda is supported for moderate Alzheimer's disease.",
  "study_support": null,
  "study_details": [],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": true,
  "rationale": "The requested Namenda XR is medically necessary for the treatment of the patient's Alzheimer's disease, as supported by the Alzheimer's Association guidelines and the patient's symptoms indicating moderate Alzheimer's.",
  "reviewer_credentials": null
}